Hospital Universitario Clinico San Cecilio,

Granada 18016

1 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, HER2-positive Breast Cancer, Metastatic HER2-positive Breast Cancer

Studies at this site

• A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer — Recruiting now
• A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer — Recruiting now